Finally, there is a positive step in prevention for HIV/AIDS on the horizon. There is a pending FDA vote on whether they will approve Truvada medication as a preventive treatment for healthy people who are at high risk through sexual intercourse. Currently there are no other drugs have been approved to prevent HIV infection. Since Truvada has been already in the market as part of a cocktail drug therapy for those already HIV infected, the pharmaceutical company would be able to advertise it as a preventive drug if the FDA approves it as such, which means more profit. What’s at stake is the health of the people if the drug is unaffordable for those at high risk in a lower economic status.